1. Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus. Issue 11 (30th August 2022) Authors: Arai, Taeang; Atsukawa, Masanori; Tsubota, Akihito; Mikami, Shigeru; Haruki, Uojima; Yoshikata, Keiichiro; Ono, Hiroki; Kawano, Tadamichi; Yoshida, Yuji; Tanabe, Tomohide; Okubo, Tomomi; Hayama, Korenobu; Nakagawa‐Iwashita, Ai; Itokawa, Norio; Kondo, Chisa; Kaneko, Keiko; Nagao, Mototsugu; Inagak... Journal: Hepatology communications Issue: Volume 6:Issue 11(2022) Page Start: 3073 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data. (March 2021) Authors: Arai, Taeang; Atsukawa, Masanori; Tsubota, Akihito; Mikami, Shigeru; Ono, Hiroki; Kawano, Tadamichi; Yoshida, Yuji; Tanabe, Tomohide; Okubo, Tomomi; Hayama, Korenobu; Nakagawa-Iwashita, Ai; Itokawa, Norio; Kondo, Chisa; Kaneko, Keiko; Emoto, Naoya; Nagao, Mototsugu; Inagaki, Kyoko; Fukuda, Izumi;... Journal: Therapeutic advances in endocrinology and metabolism Issue: Volume 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗